These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 17496007)

  • 1. Prevalence, challenges, and solutions for (18)F-FDG PET studies of obese patients: a technologist's perspective.
    Botkin CD; Osman MM
    J Nucl Med Technol; 2007 Jun; 35(2):80-3. PubMed ID: 17496007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and patterns of physiologic muscle uptake detected with whole-body 18F-FDG PET.
    Jackson RS; Schlarman TC; Hubble WL; Osman MM
    J Nucl Med Technol; 2006 Mar; 34(1):29-33. PubMed ID: 16517966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-body PET/CT studies with lowered ¹⁸F-FDG doses: the influence of body mass index in dose reduction.
    Sánchez-Jurado R; Devis M; Sanz R; Aguilar JE; del Puig Cózar M; Ferrer-Rebolleda J
    J Nucl Med Technol; 2014 Mar; 42(1):62-7. PubMed ID: 24503348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technologist radiation exposure in routine clinical practice with 18F-FDG PET.
    Guillet B; Quentin P; Waultier S; Bourrelly M; Pisano P; Mundler O
    J Nucl Med Technol; 2005 Sep; 33(3):175-9. PubMed ID: 16145226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing imaging protocols for overweight and obese patients: a lutetium orthosilicate PET/CT study.
    Halpern BS; Dahlbom M; Auerbach MA; Schiepers C; Fueger BJ; Weber WA; Silverman DH; Ratib O; Czernin J
    J Nucl Med; 2005 Apr; 46(4):603-7. PubMed ID: 15809482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of imaging protocols for 18F-FDG PET/CT in overweight patients: optimizing scan duration versus administered dose.
    Masuda Y; Kondo C; Matsuo Y; Uetani M; Kusakabe K
    J Nucl Med; 2009 Jun; 50(6):844-8. PubMed ID: 19443586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of patient weight and emission scan duration on PET/CT image quality and lesion detectability.
    Halpern BS; Dahlbom M; Quon A; Schiepers C; Waldherr C; Silverman DH; Ratib O; Czernin J
    J Nucl Med; 2004 May; 45(5):797-801. PubMed ID: 15136629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of optimized injection dose and acquisition time using body mass index for three-dimensional whole-body FDG-PET].
    Matsumoto K; Matsuura H; Minota E; Sakamoto S; Nakamoto Y; Senda M
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2004 Nov; 60(11):1564-73. PubMed ID: 15568009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-body 18F-FDG PET in recurrent or metastatic nasopharyngeal carcinoma.
    Yen RF; Hong RL; Tzen KY; Pan MH; Chen TH
    J Nucl Med; 2005 May; 46(5):770-4. PubMed ID: 15872349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of body habitus on quantitative and qualitative image quality in whole-body FDG-PET.
    Tatsumi M; Clark PA; Nakamoto Y; Wahl RL
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):40-5. PubMed ID: 12483408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose Optimization in
    Rana N; Kaur M; Singh H; Mittal BR
    J Nucl Med Technol; 2021 Mar; 49(1):49-53. PubMed ID: 32887760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT.
    Ben-Haim S; Kupzov E; Tamir A; Israel O
    J Nucl Med; 2004 Nov; 45(11):1816-21. PubMed ID: 15534049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies.
    Nanni C; Pettinato C; Ambrosini V; Spinelli A; Trespidi S; Rubello D; Al-Nahhas A; Franchi R; Alavi A; Fanti S
    Nucl Med Commun; 2007 Jul; 28(7):547-53. PubMed ID: 17538396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Variations of the hepatic SUV in relation to the body mass index in whole body PET-CT studies].
    Batallés SM; Villavicencio RL; Quaranta A; Burgos L; Trezzo S; Staffieri R; Pezzotto SM
    Rev Esp Med Nucl Imagen Mol; 2013 Jan; 32(1):26-32. PubMed ID: 23177341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET.
    Drzezga A; Grimmer T; Riemenschneider M; Lautenschlager N; Siebner H; Alexopoulus P; Minoshima S; Schwaiger M; Kurz A
    J Nucl Med; 2005 Oct; 46(10):1625-32. PubMed ID: 16204712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 2-dimensional and 3-dimensional acquisition for 18F-FDG PET oncology studies performed on an LSO-based scanner.
    Lodge MA; Badawi RD; Gilbert R; Dibos PE; Line BR
    J Nucl Med; 2006 Jan; 47(1):23-31. PubMed ID: 16391183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-FDG PET/CT for staging of penile cancer.
    Scher B; Seitz M; Reiser M; Hungerhuber E; Hahn K; Tiling R; Herzog P; Reiser M; Schneede P; Dresel S
    J Nucl Med; 2005 Sep; 46(9):1460-5. PubMed ID: 16157528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional PET/CT after water gastric inflation for evaluating loco-regional disease of gastric cancer.
    Lee SJ; Lee WW; Yoon HJ; Lee HY; Lee KH; Kim YH; Park DJ; Kim HH; So Y; Kim SE
    Eur J Radiol; 2013 Jun; 82(6):935-42. PubMed ID: 23410909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery.
    Kalff V; Duong C; Drummond EG; Matthews JP; Hicks RJ
    J Nucl Med; 2006 Jan; 47(1):14-22. PubMed ID: 16391182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.